An ETS2 Enhancer Variant May Modulate Gene Expression and Contribute to Defining a Genetic Risk Profile for SLE Susceptibility

<b>Background/Objectives</b>: Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disease strongly influenced by genetic factors. Genome-wide association studies (GWASs) have identified numerous non-coding susceptibility loci, but their functional roles remain poorly understood. The single-nucleotide variant (SNV) rs2836882, located in an enhancer near the <i>ETS2</i> proto-oncogene, has been implicated in immune regulation, though its contribution to SLE is unclear. <b>Methods</b>: We analyzed rs2836882 in 246 Italian patients with SLE and 216 matched controls using TaqMan genotyping. A weighted genetic risk score (wGRS) combining rs2836882 with other known SLE variants was calculated. <i>ETS2</i> mRNA expression was quantified by RT-qPCR in PBMCs from 60 individuals, and in silico analyses assessed the variant's functional context. <b>Results</b>: The rs2836882 risk allele was significantly associated with SLE (OR = 1.54, <i>p</i> = 0.02). Patients showed a markedly higher wGRS than controls (<i>p</i> < 0.00001), confirming an additive genetic burden. In silico data indicated that rs2836882 lies within an active enhancer region (H3K4me1/H3K27ac+) containing PU.1 binding motifs and functions as an expression quantitative trait locus (eQTL) for <i>ETS2</i>. Expression analysis demonstrated that carriers of the risk allele exhibited significantly increased <i>ETS2</i> expression compared to non-carriers (<i>p</i> = 0.002) in both groups. <b>Conclusions</b>: In conclusion, rs2836882 is a functional regulatory variant that enhances <i>ETS2</i> transcription and contributes to increased SLE susceptibility. These findings establish a mechanistic link between a non-coding GWAS locus and disease risk, emphasizing the role of regulatory variants in autoimmune pathogenesis and supporting the integration of functional non-coding variants into genetic risk models for improved patient stratification.

Authors

Institutions

Publication Details

Journal
Genes
Published
2025-12-08
DOI
https://doi.org/10.3390/genes16121462
Primary Topic
Systemic Lupus Erythematosus Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An ETS2 Enhancer Variant May Modulate Gene Expression and Contribute to Defining a Genetic Risk Profile for SLE Susceptibility

Paola Borgiani, Cinzia Ciccacci, Giada De Benedittis, Fabrizio Conti et al.
Genes
Systemic Lupus Erythematosus Research
article

An ETS2 Enhancer Variant May Modulate Gene Expression and Contribute to Defining a Genetic Risk Profile for SLE Susceptibility

Paola Borgiani, Cinzia Ciccacci, Giada De Benedittis, Fabrizio Conti, Andrea Latini, Carlo Perricone, Giuseppe Novelli, Chiara Morgante, Fulvia Ceccarelli
article en

Abstract

<b>Background/Objectives</b>: Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disease strongly influenced by genetic factors. Genome-wide association studies (GWASs) have identified numerous non-coding susceptibility loci, but their functional roles remain poorly understood. The single-nucleotide variant (SNV) rs2836882, located in an enhancer near the <i>ETS2</i> proto-oncogene, has been implicated in immune regulation, though its contribution to SLE is unclear. <b>Methods</b>: We analyzed rs2836882 in 246 Italian patients with SLE and 216 matched controls using TaqMan genotyping. A weighted genetic risk score (wGRS) combining rs2836882 with other known SLE variants was calculated. <i>ETS2</i> mRNA expression was quantified by RT-qPCR in PBMCs from 60 individuals, and in silico analyses assessed the variant's functional context. <b>Results</b>: The rs2836882 risk allele was significantly associated with SLE (OR = 1.54, <i>p</i> = 0.02). Patients showed a markedly higher wGRS than controls (<i>p</i> < 0.00001), confirming an additive genetic burden. In silico data indicated that rs2836882 lies within an active enhancer region (H3K4me1/H3K27ac+) containing PU.1 binding motifs and functions as an expression quantitative trait locus (eQTL) for <i>ETS2</i>. Expression analysis demonstrated that carriers of the risk allele exhibited significantly increased <i>ETS2</i> expression compared to non-carriers (<i>p</i> = 0.002) in both groups. <b>Conclusions</b>: In conclusion, rs2836882 is a functional regulatory variant that enhances <i>ETS2</i> transcription and contributes to increased SLE susceptibility. These findings establish a mechanistic link between a non-coding GWAS locus and disease risk, emphasizing the role of regulatory variants in autoimmune pathogenesis and supporting the integration of functional non-coding variants into genetic risk models for improved patient stratification.

GenesVol. 16(12)
University of Rome Tor Vergata (IT), University of Perugia (IT), Saint Camillus International University of Health and Medical Sciences (IT), Sapienza University of Rome (IT)
Openalex Percentile: Top 45%
Systemic Lupus Erythematosus Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.